Cephalalgia

Article	Citations
International Classification of Headache Disorders-4 – Work in Progress 1	124
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials	123
Predictive value of preoperative white and gray matter microstructural alterations for microvascular decompression outcome in classical trigeminal neuralgia	95
A missing piece in the puzzle of chronic dizziness: Dysautonomia	91
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world	79
Efficacy of different cannabinoid compounds on migraine-like responses in female rats	65
Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia	53
Visual snow vs. migraine aura: Debate summary and novel insights into the syndrome	50
Harassment in the headache field: a global web-based cross-sectional survey	50
Genetic characterization of the endocannabinoid system and psychiatric features in patients with migraine and medication overuse headache	49
Introducing the four dimensions 4D migraine scale: A composite score proposal evaluating migraine severity and treatment efficacy	49
Persistent idiopathic facial pain: Integrating headache neurology insights into interdisciplinary guidelines	45
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care	45
Evidence-based guidelines for the pharmacological treatment of migraine	44
Impact of psychiatric comorbidity, resilience and executive function on childhood and adolescent headaches: A narrative review	43
Painful nervus intermedius neuropathy attributed to Bell's palsy: The need for independent diagnostic criteria	43
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study	42
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”	42
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury	41
Depression screening in migraine - A double-edged sword	40
IHC 2025 late-breaking abstracts	40
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex	39
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies	39
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization	38
Systemic lupus erythematosus mimicking retinal migraine: a case report	36

An altered reward system characterizes chronic migraine with medication overuse headache	36
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa	36
A 7-year retrospective analysis of the management of children with acute headache presenting in a pediatric emergency department	35
2025 Highlights in migraine prevention	35
Effect of Altmetric score on manuscript citations: A randomized-controlled trial	32
Rethinking Burning Mouth Syndrome: Toward a multidimensional classification of oral dysaesthetic and perceptual disorders in ICHD-4	31
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment	31
Rethinking migraine with aura: Why cortical spreading depolarization (depression), not aura, causes headaches	31
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system	28
The non-decussating and decussating trigeminothalamic tracts in humans: A combination of connectome-based tractography and histological validation	27
How do we facilitate individuals with recurrent headache and migraine receiving evidence-based behavioral treatment?	26
Genetic variability within molecular core clock genes in cluster headache	26
Migraine attack incidence in relation to the post-ovulatory estrogen decline: A prospective cohort study	26
Recognizing solitary pontine lesion–related trigeminal neuralgia as a distinct entity: The need for an updated ICHD classification	25
Galcanezumab modulates Capsaicin-induced C-fiber reactivity	25
COVID-19 vaccination-triggered cluster headache episodes with frequent attacks	25
Guidelines Update: Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition – An experience-based update	24
Physical impairment during and between migraine attacks: A daily diary study of patients with chronic migraine	24
Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection	24
A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants	24
What is the evolutionary disadvantage of migraine?	24
miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cells	24
Greater occipital nerve block for the treatment of migraine: An umbrella review, systematic review, and meta-analysis	24
Neck pain in migraine: A narrative review and steps to correct evaluation and treatment	24
Migraine and risk of atrial fibrillation: A 9-year follow-up based on the Trøndelag Health Study	23
Case reports: Could sexual dysfunction in women with migraine be a side effect of CGRP inhibition?	23
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks	23
Overlap between perceived triggers, premonitory symptoms and symptom persistence across migraine phases: A REFORM study	22
Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®	22
Genome sequencing reveals the Adgrl3 ( ADGRL3 ) gene as a possible cause of cephalic hypersensitivity in t	22
Crossing the Rubicon? The future impact of artificial intelligence on headache medicine	22
Author response to ‘Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications’	22
Comorbidity or combination – more evidence for cluster-migraine?	21
The midfacial segment pain: little known disorder in need of scientific evaluation	21
Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study	21
Looking at Cephalalgia from the inside	21
Abstracts from the International Headache Congress 14–17 September 2023	20
Advancing understanding of migraine pathophysiology and therapy by consideration of patient sex	20
The “index vein” as a sign for migraine aura in the emergency setting	20
Plasma adrenomedullin levels in migraine: A registry for migraine (REFORM) study	20
Sex differences in photophobic behaviors following cortical spreading depression in rats	20
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society	19
Muscae volitantes: A 19th-century precursor of visual snow syndrome?	19
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process	19
Abnormal heart rate variability and its application in predicting treatment efficacy in patients with chronic migraine: An exploratory study	19
Preclinical and clinical evaluation of LY3451838, a PACAP-neutralizing monoclonal antibody, in randomized, double-blind, placebo-controlled phase 1 and phase 2 studies involving healthy adults and adu	19
Thanks to Reviewers	19
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review	19
Are we closer to achieving precision medicine for migraine treatment? A narrative review	19
Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society	18

Exploring the association between familial hemiplegic migraine genes ( CACNA1A , ATP1A2 and	18
Erratum	18
Stroke due to small-vessel disease and migraine: A case–control study of a young adult with ischemic stroke population	17
Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives	17
Premonitory symptoms in migraine: A REFORM Study	17
Corneal confocal microscopy identifies corneal nerve fiber loss in patients with migraine	17
Brain imaging in migraine with and without aura: Similarities and differences	16
The effect of treatment onset time on acute efficacy in migraine patients treating with remote electrical neuromodulation (REN)	16
Therapeutic dissociation of CGRP-targeted treatments in migraine and complex regional pain syndrome	16
Comorbidity with fibromyalgia predicted poorer outcomes in patients with chronic migraine on flunarizine: Prospective proof-of-concept study	16
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache	16
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent he	16
Internet and social media's role in migraine education: Headache or not headache?	16
Letter to the Editor regarding “Effect of Altmetric score on manuscript citations: A randomized-controlled trial”	16
Corneal confocal microscopy reveals nerve fiber alterations in migraine irrespective of subtype or visual hypersensitivity	16
The impact of eating disorders on idiopathic intracranial hypertension	16
Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies against CGRP and the CGRP receptor: A retrospective cohort study	15
New migraine drugs: A critical appraisal of the reason why the majority of migraine patients do not receive an adequate medication	15
Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension	15
Shared genetics and causal relationships between migraine and thyroid function traits	15
Hypnic Headache – What do we know in 2022?	15
Effectiveness of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in menstrually-related migraine: The unmet need of perimenstrual headache days	15
Prevalence and treatment of typical and atypical headaches in patients with Chiari I malformation: A meta-analysis and literature review	15
Recurrent Painful Ophthalmoplegic Neuropathy: A case report with atypical features and a review of the literature	14
Avoidance behaviour modulates but does not condition phonophobia in migraine	14
Proposed general diagnostic criteria for secondary headaches	14
The long-term effect of work schedule, shift work disorder, insomnia and restless legs syndrome on headache among nurses: A prospective longitudinal cohort study	14
Cigarette smoking history (personal and secondary childhood exposure) in non-cluster headache trigeminal autonomic cephalalgias: A clinic based study	14
Comment on “Lack of reproducibility of resting-state functional MRI findings in migraine with aura”	14
The clinical outcome of patients starting monoclonal antibodies anti-CGRP with concomitant migraine preventive treatments	13
“Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials	13
Reply to “Methodological considerations in assessing the impact of CGRP monoclonal antibodies on blood pressure”	13
2025 highlights in non-invasive neurostimulation and neuromodulation for headache management	13
Pan-American migraine prevalence: Findings from the Americas’ migraine observatory study (AMIGOS)	13
Headache at the chronic stage of cerebral venous thrombosis	13
Longitudinal trajectories of posttraumatic headache after pediatric mild traumatic brain injury	13
HEAD-WINd ® : A nationwide cohort study of headache disorders in danish adults using survey, smartphone and registry data	13
Comparison of continuous headache features in youth with migraine, new daily persistent headache, and persistent post-traumatic headache	13
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study	13
Corrigendum: No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study	13
Children under 6 years with acute headache in Pediatric Emergency Departments. A 2-year retrospective exploratory multicenter Italian study	13
Electrophysiological findings in migraine may reflect abnormal synaptic plasticity mechanisms: A narrative review	13
Efficacy and safety of eptinezumab in a predominantly Asian population with chronic migraine: Results of the randomized, double-blind, placebo-controlled SUNRISE trial	13
2025 Highlights in digital technology in headache	13
Generative chatbots in headache education and research: A narrative review	12
Classification of solitary pontine lesion–related trigeminal neuralgia	12
Other primary headaches: Distinct clinical features and uncertain pathophysiology	12
Transition of headache care from childhood to adulthood: Focusing needs, barriers, and models of care. A position paper of the IHS Child and Adolescent Committee	12
It's not either-or: Why migraine care needs both real-world evidence studies and randomized controlled trials	12
Adjunctive occipital nerve block for emergency treatment of acute migraine: A randomized, controlled trial	12
Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache	12
Late Breaking Author Index	12
Molecular triggers of migraine aura: A systematic review of human pharmacological provocation studies	12
Personal view: Modelling pain mechanisms of migraine without aura	12
Cephalalgia : a legacy of excellence, a vision for tomorrow	12
2025 Highlights in acute migraine treatment	12
2025 highlights in headache in children and adolescents	12
Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine	12
Orofacial pain for clinicians: A review of constant and attack-like facial pain syndromes	12
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review	12
Research to improve headache classification: Results, methods, and future challenges	12
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab	12
Severity of physical, emotional, and cognitive symptoms is associated with future persistence of acute post-traumatic headache attributed to mild traumatic brain injury	11
The psychometric properties of an e-headache diary in migraine	11
Epicranial headaches part 2: Nummular headache and epicrania fugax	11
Addressing unmet needs in migraine: Real-world fremanezumab effectiveness in participants of the PEARL study with at least three prior preventive treatment failures	11
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine	11
Oxygen inhalation has no effect on provoked cranial autonomic symptoms using kinetic oscillation stimulation in healthy volunteers	11
Multidisciplinary headache treatment with work-focus in Norway: An observational study	11
How migraine and its associated treatment impact on pregnancy outcomes: Umbrella review with updated systematic review and meta-analysis	11
Comment on ‘'Correlation between endometriosis and migraine features: Results from a prospective case-control study'‘	10
Migraine and the risk of stroke in a middle-aged and elderly population: A prospective cohort study	10
Reaching international consensus on the definition of refractory migraine using the Delphi method	10
Lack of a direct link between macular cones function and photophobia in interictal migraine	10
Overuse of analgesics can affect the fertility biomarker Anti-Müllerian Hormone in females. A translational study	10
Therapeutic dissociation of CGRP-targeted treatments in migraine and complex regional pain syndrome: Authors’ reply	10
Migraine as a primary care-sensitive condition: Building pathways to accessible care	10
Developing an artificial intelligence-based headache diagnostic model and its utility for non-specialists’ diagnostic accuracy	10
The SIH-EBP Score: A grading scale to predict the response to the first epidural blood patch in spontaneous intracranial hypotension	10
Pathophysiology of cluster headache: From the trigeminovascular system to the cerebral networks	10

Migraine and risk of hypertensive disorders of pregnancy: A population-based cohort study	10
Migraine and insufficient sleep: The effect of sleep restriction on nociceptive evoked potentials in migraine	10
Update in the understanding of new daily persistent headache	10
Recovery and long-term outcome after neurosurgical closure of spinal CSF leaks in patients with spontaneous intracranial hypotension	10
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS stud	10
Persistent headache attributed to past cervicocephalic artery dissection: clinical characteristics and contributors to headache persistence	10
Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine	10
Phenotyping non-idiopathic pseudotumor cerebri syndrome – A prospective cohort study	10
Open label experience of repeated OnabotulinumtoxinA injections towards the sphenopalatine ganglion in patients with chronic cluster headache and chronic migraine	10